Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more) An Emerging Name in Cannabis: HERB (click to learn more) AI-Driven Wellness Play on the CSE (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News InMed Pharmaceuticals Inc INM

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INM)

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Newsfile 1 day ago

InMed Announces Results of 2025 Annual General and Special Meeting

Newsfile December 17, 2025

InMed Provides Update on BayMedica Commercial Business

Newsfile December 12, 2025

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Newsfile November 18, 2025

InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Newsfile November 6, 2025

Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Newsfile October 16, 2025

InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

Newsfile October 9, 2025

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Newsfile September 23, 2025

InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Newsfile September 5, 2025
View More News ››

Opinion & Analysis (NDAQ:INM)

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

Streetwise Reports January 21, 2020

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

Hannah Genig April 1, 2019

Cannabis Technologies (C.CAN) lays out clear path to creating shareholder value

Stockhouse Editorial June 23, 2014
View More Opinion ››

Bullboard Posts (NDAQ:INM)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - November 20, 2025

InMed presents INM-901 data at 2025 Alzheimer’s Association

https://ow.ly/MZxg50WNfpr
zardoz00 - August 28, 2025

Buy buddy buy because it's taking off this morning.

Otherwise FOMO
coolfooldumbguy - June 24, 2025

Using technical analysis for this stock.

It is starting to climb upwards again today from its low prices per share and
coolfooldumbguy - June 2, 2025

INM-089 good progress on MD

https://www.inmedpharma.com/news_release/inmed-announces-inm-089-intravitreal-formulation-in-the-treatment-of-dry-age-related-macular...
zardoz00 - February 3, 2025

Buy buddy buy because it's taking off this morning.

So that you fellas should be getting on-board with this one
coolfooldumbguy - January 21, 2025
View more Bullboard ››

Stallion Uranium Corp.

Stallion Uranium Corp.

Stallion Uranium Corp. engages in the acquisition and exploration of mineral property assets in the United States and Canada. ...
View More »

Podcasts